ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL CANCER INSTITUTE

SWOG Network Group Operations Center of the NCTN

Completed
Institution
Oregon Health & Science University, OR
Principal investigator
Charles D. Blanke
Funding
$2.0M
Duration
2014–2026
Open portfolio

Moonbase score

Still being scored

Abstract

SWOG's overarching goal is to conduct high-impact cancer trials with results meaningful to our investigators and patients. In a recent analysis, SWOG investigators examined how our treatment trials have benefited patients with cancer in the general population over the course of its 60-year history (Unger, JAMA Oncol 2017). Three and one-third million life-years were gained in the population of US patients with cancer through 2015, at an investment dollar cost on the part of the NCI of $125 per life-year gained. This clearly illustrates how the NCI's investment in its cancer cooperative group research program has provided exceptional value and benefit to the American public. We will continue to develop and conduct trials aimed at making a significant, cost-effective difference for those affected by cancer.

LOADING MOONBASE SCORE

NATIONAL CANCER INSTITUTEU10benefitedgainedcancerinvestmentncipopulation patientsswogpatients cancer

Questions for Oregon Health & Science University

Answered by the team behind this research.

No questions yet. Sign in to ask the first one

Related grants

Same researchers, same institution, same topic, scored first.